FDA Inspection
Pyramid Laboratories, Inc.Pyramid Laboratories, Inc. – FDA Inspection, Apr 11, 2019
Record Details
This FDA Inspection record concerns Pyramid Laboratories, Inc., with an inspection on April 11, 2019, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 2136b73d-4285-4747-b171-b2a39ff538ac
Inspection Facts
- Inspection number
- 1085965
- FDA center
- Human Drugs
- Project area
- New Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.165(a)Testing and release for distribution
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pyramid Laboratories, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2026 | VAI | Los Angeles District Office | Drug Quality Assurance |
| September 29, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 2, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 5, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 15, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pyramid Laboratories, Inc.
- FDA Inspection 1303644 - 2026-02-13
- FDA Inspection 1153303 - 2021-09-29
- FDA Inspection 1050366 - 2018-04-02
- FDA Inspection 929256 - 2015-06-05
- FDA Inspection 910747 - 2015-01-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.